학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 60,104건 | 목록 1~20
Academic Journal
Zahran SS; Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, Egypt.; El-Gazzar MGM; Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, Egypt.; El-Gazzar MG; Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, Egypt. Electronic address: marwagalalgazzar@yahoo.com.; Ghorab MM; Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, Egypt. Electronic address: mmsghorab@yahoo.com.
Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE
Academic Journal
Brufsky AM; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Sandin R; Pfizer AB, Stockholm, Sweden.; Stergiopoulos S; Pfizer Inc., New York, New York, USA.; Chen C; Pfizer Inc., New York, New York, USA.; Karanth S; RTI Health Solutions, Research Triangle Park, Raleigh, North Carolina, USA.; Li B; Pfizer Inc., New York, New York, USA.; Esterberg E; RTI Health Solutions, Research Triangle Park, Raleigh, North Carolina, USA.; Makari D; Pfizer Inc., New York, New York, USA.; Candrilli SD; RTI Health Solutions, Research Triangle Park, Raleigh, North Carolina, USA.; Goyal RK; RTI Health Solutions, Research Triangle Park, Raleigh, North Carolina, USA.; Rugo HS; University of California San Francisco, San Francisco, California, USA.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Academic Journal
Merke DP; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.; Mallappa A; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Parker M; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Sukin C; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Kulkarni SE; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Keil MF; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.; Van Ryzin C; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Hill SC; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Reynolds JC; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.; Cutler GB Jr; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.; Sinaii N; Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE
Academic Journal
Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.; Hörner M; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.; Thill M; Department of Gynecology and Gynecological Oncology, Agaplesion Markus Krankenhaus, Frankfurt, Germany.; Banys-Paluchowski M; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.; Schmatloch S; Frauenklinik, Elisabeth-Krankenhaus Kassel, Kassel, Germany.; Fasching PA; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany. Electronic address: peter.fasching@fau.de.; Harbeck N; Breast Center, Department of Gynecology and Obstetrics and CCC Munich LMU, LMU University Hospital, Munich, Germany.; Langanke D; Frauenklinik, St. Elisabeth-Krankenhaus Leipzig, Leipzig, Germany.; Uhrig S; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.; Häberle L; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany.; Fischer D; Frauenklinik, Klinikum Ernst von Bergmann, Potsdam, Germany.; Hein A; Frauenklinik, Klinikum Esslingen GmbH, Esslingen Germany.; Fehm TN; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Düsseldorf, Germany.; Goossens C; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.; Terhaag J; Department of Gynecology and Obstetrics, Rottal Inn Kliniken, Eggenfelden, Germany.; Heilenkötter U; Klinik für Frauenheilkunde und Geburtshilfe, Klinikum Itzehoe, Itzehoe, Germany.; Dall P; Frauenklinik, Städtisches Klinikum Lüneburg, Lüneburg, Germany.; Rudlowski C; Frauenklinik, Evangelisches Krankenhaus Bergisch Gladbach, Bergisch-Gladbach, Germany.; Wuerstlein R; Breast Center, Department of Gynecology and Obstetrics and CCC Munich LMU, LMU University Hospital, Munich, Germany.; Aydogdu M; Klinik für Gynäkologie, Gynäkoonkologie und Senologie Klinikum Bremen-Mitte, Bremen, Germany.; Keyver-Paik MD; Frauenklinik des Klinikums der Stadt Wolfsburg, Wolfsburg, Germany.; Hammerle C; Frauenklinik, St. Josefs- Hospital Wiesbaden, Wiesbaden, Germany.; Deuerling N; Frauenklinik und Brustzentrum, Klinikum Fichtelgebirge gGmbH, Marktredwitz, Germany.; Stickeler E; Department of Obstetrics and Gynecology, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital of RWTH Aachen, Aachen, Germany.; Aktas B; Department of Gynecology, University of Leipzig Medical Center, Leipzig, Germany.; Belleville E; ClinSol GmbH & Co KG, Würzburg, Germany.; Thoma M; Brustzentrum, Ammerland-Klinik, Westerstede, Germany.; Ditsch N; Department of Gynecology and Obstetrics, University Hospital Augsburg, Augsburg, Germany.; Baila Y; Frauenklinik, Klinikum Kassel, Kassel, Germany.; Roos C; Novartis Pharma GmbH, Sophie-Germain-Str. 10, 90443 Nuermberg, Germany.; Mann C; Novartis Pharma GmbH, Sophie-Germain-Str. 10, 90443 Nuermberg, Germany.; Iuliano C; Novartis Pharma GmbH, Sophie-Germain-Str. 10, 90443 Nuermberg, Germany.; Brucker SY; Department of Gynecology and Obstetrics, Tübingen University Hospital, Tübingen, Germany.; Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.; Hartkopf AD; Department of Gynecology and Obstetrics, Tübingen University Hospital, Tübingen, Germany.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Academic Journal
Janni W; Department of Gynecology and Obstetrics, Ulm University, Ulm, Germany. Electronic address: Wolfgang.Janni@uniklinik-ulm.de.; Untch M; Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology, University Hospital of Munich Ludwig Maximilian, Munich, Germany.; Gligorov J; Institut Universitaire de Cancérologie, AP-HP Sorbonne Université, Paris, France.; Jacot W; Institut du Cancer de Montpellier Val d'Aurelle, Montpellier University, INSERM, Montpellier, U1194, France.; Chia S; BC Cancer Research Centre, Vancouver, BC, Canada.; Boileau JF; Montreal Jewish General Hospital, Segal Cancer Centre, McGill University, Montreal, QC, Canada.; Gupta S; Novartis Healthcare Private Limited, Hyderabad, Telangana, India.; Mishra N; Novartis Healthcare Private Limited, Hyderabad, Telangana, India.; Akdere M; Novartis Pharma AG, Basel, Switzerland.; Danyliv A; Novartis Pharma AG, Basel, Switzerland.; Curigliano G; European Institute of Oncology IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Academic Journal
Hu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Zhang Q; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.; Sun T; Department of Medical Oncology, Cancer Hospital of China Medical University/Liaoning Cancer Hospital, Shenyang, Liaoning 110042, China.; Yin Y; Department of Oncology, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.; Li H; Department of Breast Oncology, Peking University Cancer Hospital & Institute 100142, Beijing, China.; Yan M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450052, China.; Tong Z; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.; Li M; Department of Oncology, Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.; Teng Y; Department of Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.; Oppermann CP; Centro de Pesquisa Clínica de Oncologia e Hematologia, Hospital Mãe de Deus/AESC, Porto Alegre, Brazil.; Kanakasetty GB; Department of Medical Oncology, HCG Hospitals and Kidwai Memorial Institute of Oncology, Bangalore, India.; Portugal MC; Clinical Trial Department, Eastleigh Breast Care Center, Pretoria, South Africa.; Yang L; Eli Lilly and Company, Shanghai 200021, China.; Zhang W; Eli Lilly and Company, Shanghai 200021, China.; Jiang Z; Department of Breast Cancer, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.
Publisher: Chinese Medical Association ; produced by Wolters Kluwer Country of Publication: China NLM ID: 7513795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2542-5641 (Electronic) Linking ISSN: 03666999 NLM ISO Abbreviation: Chin Med J (Engl) Subsets: MEDLINE
Academic Journal
Agrawal YN; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Division of Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Fernández-Martínez A; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Department of Genetics, University of North Carolina, Chapel Hill, NC.; Gil-Gil M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Institut Català d'Oncologia (ICO) & IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Zielinski C; CECOG, Central European Cooperative Oncology Group, Vienna, Austria.; Vienna Cancer Center, Medical University of Vienna and Vienna Hospital Association, Vienna, Austria.; Ruiz-Borrego M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Ciruelos EM; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology Department, Breast Cancer Unit, University Hospital 12 de Octubre, Madrid, Spain.; HM Hospitales, Madrid, Spain.; SOLTI Group on Breast Cancer Research, Barcelona, Spain.; Muñoz M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitari Clinic de Barcelona, Institut del Càncer i malalties de la sang, IDIBAPS, Barcelona, Spain.; Margelí M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Badalona Applied Research Group in Oncology (ARGO Group), Institut Catalá D'Oncologia, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.; Bermejo B; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria-INCLIVA, Valencia, Spain.; Facultad de medicina de la Universidad de Valencia, Valencia, Spain.; Antón A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón-IISA, Zaragoza, Spain.; Kahan Z; CECOG, Central European Cooperative Oncology Group, Vienna, Austria.; Department of Oncotherapy, University of Szeged, Szeged, Hungary.; Csöszi T; CECOG, Central European Cooperative Oncology Group, Vienna, Austria.; Semmelweis University, Pankreász Betegségek Intézete, Budapest, Hungary.; Alonso-Romero JL; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen de La Arrixaca-IMIB, Murcia, Spain.; García-Saenz JÁ; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain.; Sánchez-Rovira P; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Unit, Universitary Hospital Jaén, Jaén, Spain.; Álvarez E; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Lucus Augusti, Lugo, Spain.; Chacón JI; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario de Toledo, Toledo, Spain.; González-Santiago S; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario San Pedro de Alcantara, Cáceres, Spain.; Rodríguez CA; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario de Salamanca-IBSAL, Salamanca, Spain.; Servitja S; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital del Mar, Barcelona, Spain.; Pfefferle AD; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Department of Genetics, University of North Carolina, Chapel Hill, NC.; Herranz J; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Liu Y; Former Pfizer employee, La Jolla, CA.; Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Division of Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Romero-Camarero I; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Caballero R; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Guerrero-Zotano Á; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología (IVO), Valencia, Spain.; Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Department of Genetics, University of North Carolina, Chapel Hill, NC.; Martín M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Maranon, Madrid, Spain.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Casabella A; IRCCS Policlinico San Martino, Genoa, Italy. andrea.casabella@hsanmartino.it.; Paladin F; Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.; Bighin C; IRCCS Policlinico San Martino, Genoa, Italy.; Ottaviani S; Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.; Marelli C; Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy.; Ponzano M; Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy.; Signori A; Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy.; Murdaca G; Department of Internal Medicine, Internal Medicine Unit, University of Genoa, Genoa, Italy.; Cutolo M; IRCCS Policlinico San Martino, Genoa, Italy.; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy.; Molfetta L; Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy.; Nencioni A; Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.; Paolino S; IRCCS Policlinico San Martino, Genoa, Italy. sabrina.paolino@unige.it.; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy. sabrina.paolino@unige.it.; Del Mastro L; IRCCS Policlinico San Martino, Genoa, Italy. lucia.delmastro@unige.it.; Section of Medical Oncology, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy. lucia.delmastro@unige.it.; Monacelli F; Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.
Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1970-9366 (Electronic) Linking ISSN: 18280447 NLM ISO Abbreviation: Intern Emerg Med Subsets: MEDLINE
Academic Journal
Uzmez ZL; Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.; Osmaniye D; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.; Central Analysis Laboratory, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.; Ozkay Y; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.; Central Analysis Laboratory, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.; Kaplancıklı ZA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.
Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101240303 Publication Model: Print Cited Medium: Internet ISSN: 1875-6638 (Electronic) Linking ISSN: 15734064 NLM ISO Abbreviation: Med Chem Subsets: MEDLINE
Academic Journal
Bender CM; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA. cbe100@pitt.edu.; Sereika SM; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Gentry AL; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Zhu Y; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Wagner M; Case Western Reserve University Frances Payne Bolton School of Nursing, Cleveland, OH, USA.; Cuglewski C; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Duquette J; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Grove G; Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, USA.; Cummings M; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Cho MG; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Brufsky AM; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Diego EJ; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; McAuliffe PF; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Marsland AL; Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, USA.; Conley YP; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.; Erickson KI; Adventhealth, Orlando, FL, USA.
Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
Report
A Phase III Trial to Compare the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus an Aromatase Inhibitor (AI) vs. Trastuzumab Plus an AI vs. Lapatinib Plus an AI as 1st- or 2nd- Line Therapy in Postmenopausal Subjects With Hormone Receptor+, HER2-positive Metastatic Breast Cancer (MBC) Who Received Prior Trastuzumab and Endocrine Therapies
Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, Press MF, Tjulandin S, Iwata H, Simon SD, Kenny S, Sarp S, Izquierdo MA, Williams LS, Gradishar WJ. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE. J Clin Oncol. 2018 Mar 10;36(8):741-748. doi: 10.1200/JCO.2017.74.7824. Epub 2017 Dec 15.
Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, Press MF, Tjulandin S, Iwata H, Simon SD, Kenny S, Sarp S, Izquierdo MA, Williams LS, Gradishar WJ. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE. J Clin Oncol. 2021 Jan 1;39(1):79-89. doi: 10.1200/JCO.20.01894. Epub 2020 Aug 21.
Academic Journal
Hosseinian Z; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Lehan A; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Powers JM; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Melendez A; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Fisher HM; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States of America.; Shelby R; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States of America.; Somers T; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States of America.; Keefe F; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States of America.; Paice J; Department of Medicine (Hematology and Oncology), Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Kimmick G; Department of Medicine, Duke University, Durham, NC, United States of America.; Burns J; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Flores AM; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America; Department of Physical Therapy and Human Movement Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, United States of America.; Fox RS; University of Arizona College of Nursing, Division of Advanced Nursing Practice and Science, Tuscon, AZ, United States of America.; Kaiser K; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.; Farrell D; People Designs, Inc., Durham, NC, United States of America.; Westbrook K; Department of Medicine, Duke University, Durham, NC, United States of America; Duke Cancer Institute, Duke University Medicine Center, Durham, NC, United States of America.; Rini C; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, United States of America. Electronic address: Christine.rini@northwestern.edu.
Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Report
Phase II Trial of Primary Endocrine Therapy With Combination of Fulvestrant or an Aromatase Inhibitor and Palbociclib in Elderly Patients With Hormone Responsive Breast Cancer Who Have Inoperable Tumor Or Operable Tumor But Cannot Undergo Surgery Due to Frailty Or Who Refuse Surgery
Academic Journal
Hong RX; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Xu F; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Xia W; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Teng YE; Department of Breast Internal Medicine, The First Hospital of China Medical University, Shenyang, China.; Ouyang QC; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China.; Zheng QF; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Yuan ZY; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Chen DS; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Jiang KK; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Lin Y; Breast Disease Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Dai Z; Chengdu Center for Disease Control and Prevention, Chengdu, China.; Liu XL; Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China.; Chen QJ; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Wu XH; Department of Breast Cancer, Hubei Cancer Hospital, Wuhan, China.; Shi YX; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Huang JJ; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; An X; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Xue C; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Bi XW; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Chen MT; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Li H; Department of Breast Surgery, Sichuan Cancer Hospital, Chengdu, China.; Yao HR; Breast Tumor Centre, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Zou GR; Department of Oncology, Panyu District Cancer Institute, Panyu Central Hospital, Guangzhou, China.; Huang H; Department of Breast Surgery, Lianjiang People's Hospital, Lianjiang, China.; Zhang JM; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Wang SS; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Shen X; College of Fisheries and Life Science, Dalian Ocean University, Dalian, Liaoning, 116023, China.; Key Laboratory of Environment Controlled Aquaculture (Dalian Ocean University), Ministry of Education, Dalian, 116023, China.; Yan H; College of Fisheries and Life Science, Dalian Ocean University, Dalian, Liaoning, 116023, China. yanhongwei@dlou.edu.cn.; Key Laboratory of Environment Controlled Aquaculture (Dalian Ocean University), Ministry of Education, Dalian, 116023, China. yanhongwei@dlou.edu.cn.; Hu M; College of Fisheries and Life Science, Dalian Ocean University, Dalian, Liaoning, 116023, China.; Key Laboratory of Environment Controlled Aquaculture (Dalian Ocean University), Ministry of Education, Dalian, 116023, China.; Zhou H; College of Fisheries and Life Science, Dalian Ocean University, Dalian, Liaoning, 116023, China.; Zhang Q; College of Fisheries and Life Science, Dalian Ocean University, Dalian, Liaoning, 116023, China.; Gao R; Key Laboratory of Environment Controlled Aquaculture (Dalian Ocean University), Ministry of Education, Dalian, 116023, China.; College of Marine Science and Environment Engineering, Dalian Ocean University, Dalian, Liaoning, 116023, China.; Liu Q; Key Laboratory of Environment Controlled Aquaculture (Dalian Ocean University), Ministry of Education, Dalian, 116023, China.; College of Marine Science and Environment Engineering, Dalian Ocean University, Dalian, Liaoning, 116023, China.; Sun Q; Dalian Tian Zheng Co., Ltd, Dalian, Liaoning, China.
Publisher: BioMed Central Country of Publication: England NLM ID: 100965258 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2164 (Electronic) Linking ISSN: 14712164 NLM ISO Abbreviation: BMC Genomics Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Aromatase inhibitor
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어